Search Results - "Hernández Fernández, Diana Rosa"

Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models by Bermúdez-Abreut, Ernesto, Bergado Báez, Gretchen, Martínez Pestano, Melissa, Attanasio, Giuseppe, Gonzales Castillo, Carlos Yordan, Hernández Fernández, Diana Rosa, Alvarez-Arzola, Rydell, Alimonti, Andrea, Sánchez-Ramírez, Belinda

“…Despite the cumulative evidence supporting HER3 as a target for antitumor therapies, no agents targeting HER3 have been approved for cancer treatment. Most of…”
Get full text

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies by Bergado-Báez, Gretchen, Gonzalez Suarez, Narjara, García, Lisset Chao, Pérez-Martínez, Dayana, Hernández-Fernández, Diana Rosa, Fundora-Barrios, Talia, Rodríguez-Álvarez, Antonio, Díaz-Ordaz, Geidy Diana, Lindzen, Moshit, Yarden, Yosef, Sánchez-Ramírez, Belinda

“…Background Antitumor therapies targeting HER1/EGFR and HER2, such as monoclonal antibodies (MAbs) and tyrosine-kinase inhibitors (TKIs), have demonstrated a…”
Get full text

Immuno-toxicological evaluation of her1 cancer vaccine in non-human primates: a 6-month subcutaneous study by Mancebo Rodríguez, Axel, Bergado Báez, Gretchen, Acosta Lago, Eric, León Goñi, Avelina, Blanco Gámez, Diuris, Fuentes Morales, Dasha, Hernández Fernández, Diana Rosa, Sánchez Ramírez, Belinda, Pérez Barreda, Aylen, Casacó Parada, Ángel

“…Purpose: A vaccine composition based on the extracellular domain of the human epidermal growth factor receptor 1 (HER1-ECD) and the combination of VSSP (very…”
Get full text

Anti-proliferative and pro-apoptotic effects induced by simultaneous inactivation of HER1 and HER2 through endogenous polyclonal antibodies by Suárez, Narjara González, Báez, Gretchen Bergado, Rodríguez, Mabel Cruz, Pérez, Amelia Gutiérrez, García, Lisset Chao, Hernández Fernández, Diana Rosa, Pous, Judith Raymond, Ramírez, Belinda Sánchez

“…The human epidermal growth factor receptor (HER1) and its partner HER2 are extensively described oncogenes and validated targets for cancer therapy. However,…”
Get full text

HER1-ECD vaccination dispenses with emulsification to elicit HER1-specific anti-proliferative effects by Alpízar, Yeranddy Aguiar, Ramírez, Belinda Sánchez, Hernández Fernández, Diana Rosa, Capote, Ailem Rabasa, Hidalgo, Greta Garrido, Pérez Rodríguez, Rolando, Fernández Molina, Luis Enrique

“…EGFR (HER1) highlights as one of the most relevant tumour associated antigen in epithelial malignant cells. Monoclonal antibodies and tyrosine kinase…”
Get full text

Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine by Ramírez, Belinda Sánchez, Alpízar, Yeranddy Aguiar, Fernández, Diana Rosa Hernández, Hidalgo, Greta Garrido, Capote, Ailem Rabasa, Rodríguez, Rolando Pérez, Fernández, Luis Enrique

“…Abstract Up to now clinical experiences focusing EGF receptor, an attractive target for cancer therapy, have been limited to passive therapies, suggesting that…”
Get full text